ROWAN Study of TheraSphere with Durvalumab and Tremelimumab in HCC Completed Enrollment
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ROWAN #TheraSphere #Durvalumab #Tremelimumab #HCC
3
0
0
0